Cargando…
Towards disease-oriented dosing of rapamycin for longevity: does aging exist or only age-related diseases?
Both individuals taking rapamycin, an anti-aging drug, and those not taking it will ultimately succumb to age-related diseases. However, the former, if administered disease-oriented dosages for a long time, may experience a delayed onset of such diseases and live longer. The goal is to delay a parti...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Impact Journals
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10415559/ https://www.ncbi.nlm.nih.gov/pubmed/37477535 http://dx.doi.org/10.18632/aging.204920 |